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Alpers disease mutations in human
DNA polymerase gamma cause
catalytic defects in mitochondrial
DNA replication by distinct
mechanisms
Yufeng Qian*†, Jessica L. Ziehr and Kenneth A. Johnson*
Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX, USA
The human mitochondrial DNA polymerase gamma (Pol-γ) is nuclearly encoded and
is responsible for the replication and repair of the mitochondrial genome. Mutations
S305R and P1073L in the POLG gene have been reported to be associated with
early childhood Alpers syndrome. One patient harboring both mutations as compound
heterozygous died at 2 years of age after disease onset at 9 months. Quantitative
kinetic analysis on purified enzyme showed that the S305R mutation reduces the DNA
binding affinity by 10-fold, and reduces the specificity constant (kcat/Km) for correct
nucleotide incorporation by fourfold. It also causes a ∼threefold reduction in the excision
rate to remove mismatched nucleotides. Compared to the wild-type Pol-γ, the S305R
mutant showed no product formation in a reconstituted rolling circle replisome assay.
Interestingly, the P1073L mutant exhibited wild-type activity in single turnover kinetics to
quantify changes in kcat/Km, kcat, kexo, or processivity, and showed a twofold decrease
in the net polymerization rate in the reconstituted replisome assay, while in yeast,
P1073L caused a 60–70% mtDNA reduction in haploid cells. The heterozygous diploid
yeast cells carrying S305R and P1073L mutations in trans showed ∼75% reduction of
mtDNA content, relative to homozygous diploid cells with two wild-type alleles. Taken
together, we show clearly in both the rolling circle and the humanized yeast system that
the P1073L mutation caused significant defects in mtDNA replication, and our results
suggest a role for P1073 in the functioning of the Pol-γ with the mitochondrial DNA
helicase, and provide a rationale for understanding the physiological consequences of
the S305R/P1073L compound heterozygote in humans.
Keywords: human mitochondria, alpers, Pol-γ mutations, kinetics, yeast, replisome
Introduction
Human mitochondrial DNA is replicated and repaired by DNA polymerase gamma (Pol-γ),
which is a heterotrimer composed of a large catalytic subunit (Pol-γA) containing the DNA
polymerase active site and the 3′−5′exonuclease for proofreading activity, and two copies of the
accessory protein (Pol-γB), which facilitates processive DNA synthesis by improving the ground
state nucleotide binding and increasing the rate of chemistry (Johnson et al., 2000; Lee et al., 2009).
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The Pol-γ holoenzyme functions in conjunction with the mito-
chondrial DNA helicase (AKA Twinkle; Spelbrink et al., 2001)
and single-stranded DNA-binding protein (mtSSB), forming the
minimal replisome (Korhonen et al., 2004; Qian et al., 2013).
To date more than 200 mutations have been reported in
the POLG gene (see http://tools.niehs.nih.gov/polg/) and they
are correlated with a variety of mitochondrial disorders, includ-
ing Alpers syndrome, progressive external ophthalmoplegia
(PEO), Parkinsonism, and other encephalomyopathies associated
with mtDNA mutations, deletions, and depletions (Stumpf and
Copeland, 2011). The progressive, late-onset neurodegenerative
diseases (PEO, Parkinsonism, etc.) are often caused by muta-
tions in the active site of Pol-γA (Stumpf and Copeland, 2011),
which can lead to reductions in kcat/Km, kcat, and ﬁdelity of
replication (Batabyal et al., 2010; Estep and Johnson, 2011; Ziehr
et al., unpublished). Reduced ﬁdelity leads to the accumulation
of mutations (Qian et al., 2014), while stalling of the polymerase
can lead to double strand breaks and DNA depletion (Atanassova
et al., 2011; Estep and Johnson, 2011). On the other hand, patients
with Alpers syndrome have shown early childhood disease onset,
and the symptoms are characterized by intractable epilepsy, psy-
chomotor retardation, and hepatic failure, which leads to early
death (Wong et al., 2008; Baruﬃni et al., 2011; Tang et al., 2011;
Farnum et al., 2014). Manifestation of Alpers syndrome typi-
cally requires the presence of at least two recessive mutations in
Pol-γ, usually in compound heterozygous states, and is mostly
associated with mtDNA depletions (Wong et al., 2008). However,
the eﬀects of individual recessive mutations on protein function
and detailed molecular mechanism of pathogenesis remain to be
investigated.
Euro et al. (2011) attempted to cluster Alpers mutations into
ﬁve postulated functional domains based upon structure and
homology to model polymerases. This clustering of mutations
into various structural subdomains has been used to rationalize
the severity of the diseases according to the expected magnitude
of the biochemical defect and to establish guidelines for predict-
ing the clinical eﬀects of new point mutations (Euro et al., 2011;
Farnum et al., 2014). However, even within the known functional
domains, it is still diﬃcult to predict the magnitude of the bio-
chemical eﬀect of any particular mutation and only a handful
of point mutations have been characterized in detail (Batabyal
et al., 2010; Estep and Johnson, 2011; Sohl et al., 2013; Ziehr
et al., unpublished). Even though several mutations in Pol-γA
have been shown to cause reductions in kcat/Km, kcat, processiv-
ity, ﬁdelity, and the rate of exonuclease proofreading (Batabyal
et al., 2010; Lee et al., 2010; Ziehr et al., unpublished), predict-
ing the physiological consequences of these changes is diﬃcult.
Moreover, mutations can aﬀect the interactions between Pol-γA
and Pol-γB (Lee et al., 2010), or the TWINKLE and there are cur-
rently no reliable assays to quantify the eﬀects of point mutations
on these interactions. Predicting the clinical phenotype is further
compounded by the presence of a wild-type polymerase allele (or
one containing a diﬀerent mutation), the complex interplay of
enzymes during mtDNA replication, and the high mtDNA copy
number (Qian et al., 2014).
We previously developed a ‘humanized’ yeast system (Qian
et al., 2014) with the yeast Pol-γ MIP1 gene replaced by human
FIGURE 1 | Locations of Ser-305 and Pro-1073. The figure was drawn
using 3IKM.pdb with duplex DNA based upon alignment of T7 DNA
polymerase (1T7P.pdb).
Pol-γ, and showed the feasibility of using the ‘humanized’ yeast to
study the molecular mechanism of pathogenicity of some human
POLG mutations. In the current work, we chose to examine
two Alpers mutations: S305R and P1073L (Figure 1), respec-
tively, (Wong et al., 2008; Baruﬃni et al., 2011; Tang et al., 2011;
Farnum et al., 2014). One case was reported for a patient carrying
both S305R and P1073L mutations as compound heterozygotes
(Baruﬃni et al., 2011). The patient showed onset of Alpers syn-
drome at 9 months after birth and died at 2 years of age (Baruﬃni
et al., 2011). This rare, severe phenotype may suggest that these
two mutant enzymes do not complement each other in mtDNA
replication and led to the proposal that Ser-305 and Pro-1073
may be involved in a similar function (Euro et al., 2011). We
previously reported that S305R mutant displayed a mild reduc-
tion in kcat/Km as measured using single turnover kinetics (Qian
et al., 2014). In this work, we quantiﬁed the eﬀects of each single
point mutation on polymerase activity by Pol-γ alone and with
the TWINKLE during DNA polymerization catalyzed by a recon-
stituted replisome. In addition, we examined the consequences of
these two mutations on mtDNA replication in ‘humanized’ yeast
cells expressing human Pol-γ (Qian et al., 2014). We showed that
S305R and P1073L mutations cause mtDNA replication defects
by diﬀerent kinetic mechanisms, and our ﬁndings provided a
rationale to understand the physiological consequences of the
S305R/P1073L compound heterozygote.
Materials and Methods
Purification of Pol-γA and Pol-γB
Wild-type and mutant Pol-γA were expressed in insect cells and
puriﬁed to homogeneity as described previously (Batabyal et al.,
2010). Pol-γB was expressed in Escherichia coli and puriﬁed to
homogeneity as described (Johnson et al., 2000; Qian et al., 2013).
Cloning, Expression, and Purification of
TWINKLE
The human mitochondrial DNA helicase (TWINKLE) with an
N-terminal His tag and lacking the ﬁrst 43 amino acids, was
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cloned into pcIts ind+ plasmid, and expressed in C2984H cells.
The large-scale expression (6 L) was induced at an OD of 4.7
with temperature change to 37◦C and addition of Nalidixic acid
to a ﬁnal concentration of 50 mg/ml. The cultures were then
grown overnight to a ﬁnal OD of 13.7 and pelleted at 6,500 × g
for 20 min at 4◦C. For protein puriﬁcation, the cell pellet was
re-suspended in ﬁve volumes (mass to volume) of Lysis buﬀer
(50 mM Tris-HCl pH 7.5, 50 mMNaCl, 20 mM imidazole, 5 mM
MgCl2.6H2O, 0.1 mM PMSF, 10% Glycerol, 0.5% Nonidet-P40)
for 20 min. A Dounce A homogenizer was used to ensure uni-
form suspension. Lysozymewas then added to the suspension to a
ﬁnal concentration of 50μg/ml and stirred on ice for 15 min. The
NaCl concentration was then brought to 500 mM and 1 mMATP
was added to the cell lysate before sonicating for 15 min. This was
followed by centrifugation to pellet the debris at 55,000 × g RCF
for 30 min at 4◦C in a Beckman 45Ti. The supernatant then incu-
bated for 20 min on ice with Ni-Sepharose beads (GE Healthcare)
pre-equilibrated with Lysis buﬀer +1 mM ATP + 500 mMNaCl.
The Ni-Sepharose beads were then pelleted at 700 × g RCF for
20 min at 4◦C. The pelleted beads and minimal residual super-
natant volume were transferred to a jacketed column with water
bath set to 4◦C and allowed to pack. The column was then
washed with 10 column volumes (CVs) of Lysis buﬀer +1 mM
ATP + 500 mM NaCl. Next, the column was washed with ﬁve
CV of Nickel Column Wash 1 (30 mM Tris-HCl pH 7.5, 20%
Glycerol, 0.5% Nonidet-P40, 1 mM β-ME, 5 mM MgCl2.6H2O,
0.1 mM PMSF, 0.2 mM ATP, 0.5 M NaCl, 20 mM imidazole)
followed by a wash with Nickel Column Wash 2 (30 mM Tris-
HCl pH 7.5, 20% Glycerol, 0.5% Nonidet-P40, 1 mM β-ME,
5 mMMgCl2.6H2O, 0.1 mM PMSF, 0.2 mM ATP, 350 mMNaCl,
20 mM imidazole). The protein was then eluted with a linear
gradient from 0 to 100% Nickel Column Elution Buﬀer (30 mM
Tris-HCl pH 7.5, 20% Glycerol, 0.5% Nonidet-P40, 1 mM β-ME,
5 mMMgCl2.6H2O, 0.1 mM PMSF, 0.2 mM ATP, 350 mMNaCl,
250mM imidazole) over ﬁve CV. Fractions were collected and the
peak fractions were pooled for further puriﬁcation on three tan-
dem columns: Q-Sepharose followed by two Heparin Sepharose
columns. Columns were washed with 10 CV of Heparin Column
Buﬀer A (30 mM Tris-HCl pH 7.5, 20% Glycerol, 0.5% Nonidet-
P40, 1 mM β-ME, 5 mM MgCl2.6H2O, 0.1 mM PMSF, 350 mM
NaCl, 0.2 mM ATP) and the Q-column was removed. The pro-
tein was then eluted oﬀ of the Heparin Sepharose columns with
a steep gradient to Heparin Column Buﬀer B (30 mM Tris-HCl
pH 7.5, 20% Glycerol, 0.5% Nonidet-P40, 1 mM β-ME, 5 mM
MgCl2.6H2O, 0.1 mM PMSF, 1 M NaCl, 0.2 mM ATP). The
TWINKLE peak eluted at about 550–600 mM NaCl and frac-
tions were pooled, concentration estimated by Bradford assay,
aliquoted, and ﬂash frozen in liquid nitrogen. concentrations of
TWINKLE were given in the unit of hexamers, unless otherwise
mentioned.
Cloning, Expression, and Purification of
mtSSB
The human cDNA for mtSSB was obtained from OriGene
(Rockville, MD, USA). The coding sequence for the gene was
examined using MitoProt which indicated that the ﬁrst 20 amino
acids had the highest probability for the mitochondrial targeting
sequence (Claros and Vincens, 1996). The mtSSB mature cod-
ing sequence (codons 21 through 148) of the gene was ampli-
ﬁed by PCR and subcloned into expression vector pcIts ind+
(Brandis and Johnson, 2009), which was transformed into E.
coli C2984 competent cells to over-express the protein follow-
ing chemical and temperature induction as described (Brandis
and Johnson, 2009). The cell pellets (20 g) were thawed on
ice in ﬁve volumes of Lysis Buﬀer (HEPES, pH 7.6; 0.25 mM
EDTA; and 1 mM DTT) plus 1 tablet of protease inhibitor cock-
tails (Roche, NJ, USA). The re-suspended cells were lysed by
sonication and cell debris were removed by centrifugation at
1,5000 × g for 30 min at 4◦C. The supernatant was loaded
onto an Aﬃ-gel Blue column (1.6 cm × 10 cm) equilibrated
with Lysis Buﬀer + 50 mM NaCl at a ﬂow rate of 1 ml/min
at 4◦C. The aﬃnity column was washed with ﬁve CV of Lysis
Buﬀer + 50 mM KCl followed by ﬁve CV of Lysis Buﬀer plus
800 mM NaCl. The mtSSB was eluted with ﬁve CV Lysis Buﬀer
plus 0.5 M KSCN. The eluent was collected and protein was
precipitated by adding ammonium sulfate to 35% (w/v) sat-
uration and stirring on ice for 1 h. The protein precipitate
was collected by centrifugation at 17,000 × g for 15 min at
4◦C. The protein pellet was dissolved in 10 ml Dialysis Buﬀer
(25 mM HEPES, pH 7.6; 50 mM NaCl, 0.1 mM EDTA, 2 mM
DTT, 10% glycerol) and dialyzed against the same buﬀer for
4 h at 4◦C. The dialyzate was loaded onto a Hi-TRAP SP col-
umn (5 ml) equilibrated with Dialysis Buﬀer, and mtSSB was
eluted with a linear 0.05−0.5 M salt gradient. The fractions
containing mtSSB to pool were determined by 12% SDS-PAGE
to ensure purity (estimated at >95%). The ﬁnal concentra-
tion of mtSSB was determined using the extinction coeﬃcient
ε280 = 19,060 M−1cm−1 for monomers. The concentrations of
mtSSB were given in the unit of tetramers, unless otherwise
mentioned.
Nucleotide Incorporation Assays
Single nucleotide incorporation assays were performed with
a RQF-3 rapid quench ﬂow instrument (KinTek Corp.) as
described (Batabyal et al., 2010; Estep and Johnson, 2011). For
a typical nucleotide incorporation assay, 100 nM Pol-γ exo+
enzymewas preincubated with 75 nM 5′-γ-32P-labeledDNA tem-
plate (25-mer/45-mer duplex) on ice for 10 min, and the complex
was rapidly mixed with 12.5 mM Mg2+ and varying concentra-
tions of dATP for variable time at 37◦C before the reaction was
quenched by mixing with 250 mM EDTA. The products were
resolved on a denaturing polyacrylamide sequencing gel, and
then the dried gel was exposed to a phosphor screen (Molecular
Dynamics). The imaging and quantiﬁcation were performed as
described (Qian et al., 2014). The data have been ﬁt globally
using the KinTek Explorer program (KinTek Corp.) to the model
shown in Scheme 1, and kinetic parameters kcat and kcat/Km were
derived for Scheme 1 by the simple relationship kcat = kpol and
Km = Kd,app.
Excision Reactions
Enzyme Pol-γ exo+ (100 nM) was preincubated with 75 nM
DNA containing one T:T mismatch at the 3′ end of the primer.
The reaction was initiated by mixing it with Mg2+ (10 mM)
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for variable time at 37◦C and was then quenched by 250 mM
EDTA. The loss of full-length substrate primer due to exonuclease
digestion was plotted against time and ﬁt to a single exponential
equation to derive the rate of excision (kexo).
Replisome Assays on the Rolling-Circle
Template
The 60-mer/70-mer mini-circle DNA substrate was made as
described (Qian et al., 2013). The Pol-γ (50 nM) was pre-
incubated with 2.5 nM DNA substrate (60-mer/70-mer), 50 nM
TWINKLE (hexamer concentration) at 37◦C for 30min in a reac-
tion buﬀer containing 20 mM Tris-Cl, pH 7.5, 20 mM NaCl,
10 mM MgCl2, 3.6 mM ATP, 10% glycerol, 4 mM dithiothreitol,
250 μM dGTP, 50 μM dCTP, 1 μM α-32P-dCTP. The reac-
tion mixture was then mixed with 250 μM TTP and 250 μM
dATP for 1 min before addition of 500 nM mtSSB tetramer
and aliquots were removed at indicated time points and were
quenched by 250 mM EDTA. The product was resolved on
a 0.8% alkaline agarose gel (12 × 14 cm) containing 50 mM
NaOH and 1 mM EDTA at 1.5 v/cm for 20 h. Gels were neu-
tralized by soaking in 6% trichloroacetic acid for 30 min and
were dried onto DE81 ﬁlter paper (Whatman) and the radioactive
bands were detected by PhoshorImaging techniques as described
above.
Processive Polymerization Assays
Processive polymerization by wild-type and the P1073L mutant
of Pol-γA was monitored in the rapid quench ﬂow instrument.
For the wild-type enzyme assay, 150 nM Pol-γ exo+ enzyme was
preincubated with 75 nM 5′-γ-32P-labeled DNA template (25-
mer primer/73-mer template) for 10 min on ice, before rapidly
mixing with 12.5 mM MgCl2, 5 μM dATP, 5 μM dGTP, and
5 μM TTP at 37◦C for various times and quenching with 0.5 M
EDTA. For the P1073L mutant, 150 nM Pol-γ exo+ P1073L
enzymewas preincubated with 75 nM 5′-γ-32P-labeledDNA tem-
plate (25-mer primer/45-mer template) for 10 min on ice, before
rapidly mixing with 12.5 mM MgCl2, 5 μM dATP, 5 μM dCTP,
and 5 μM TTP at 37◦C for various times and quenching with
0.5 M EDTA. The products of processive polymerization (26-
mer to 35-mer for wild-type and 26-mer to 30-mer for P1073L
mutant) were resolved by denaturing polyacrylamide gel elec-
trophoresis (15% acrylamide, 8 M urea). The dried gel was
exposed to a storage phosphor screen and subsequently scanned
and quantiﬁed using a Typhoon scanner and ImageQuant soft-
ware (GE).
DNA Sequences
25-mer primer: 5′-GCCTCGCAGCCGTCCAACCAACTCA-3′
45-mer template: 5′-GGACGGCATTGGATCGAGGTTGAGT
TGGTTGGACGGCTGCGAGGC-3′
73-mer template: 5′-CCCCACCTGCAGGCATGCAAGCTTGG
CACTGGCCGTCGTTTTACCTCTTGAGTTGGTTGGACGGC
TGCGAGGC-3′
Humanized Yeast Strains
The haploid cells with the MIP1 replaced by Pol-γ S305R
or Pol-γ P1073L were constructed using the genomic targeting
technique as described previously (Qian et al., 2014). The
heterozygous diploid cells were constructed by mating between
the MATα type of haploid strains (mip1::Pol-γP1073L) with the
MATa type of haploid strains (mip1::Pol-γS305R) as described
previously (Qian et al., 2014).
Miscellaneous Methods
Methods for measurement of petite frequency, mutation fre-
quency, mtDNA contents, and growth curve analysis were
described previously (Qian et al., 2014).
Results
Pre-steady-State-Burst Kinetics
For wild-type Pol-γ, dissociation of the DNA from the enzyme-
DNA binary complex is the rate-limiting step during steady
state single turnover experiments, and the rate of this step
(koﬀ) governs the steady-state rate (kss). To determine whether
the mutation aﬀects the steady-state rate, primer extension
assays were performed with a total enzyme concentration of
100 nM and 350 nM DNA template (25-mer/45-mer). After pre-
incubation to form a binary complex, reactions were started
by the addition of correct incoming nucleotide (dATP) to a
ﬁnal concentration of 50 μM and product (26-mer) forma-
tion was allowed up to 8 s. The amount of product was
quantiﬁed, plotted against time, and ﬁt to a burst equation
([product] = A · (1−e−kt) kss · t) to obtain the steady-state rate
(kss) during the single nucleotide incorporation (Figure 2A).
The koﬀ was derived by the equation (koﬀ = kss/A), where A is
the concentration of active enzyme-DNA complex. Compared
to the wild-type enzyme, the S305R mutant shows a 60-
fold increase of koﬀ from 0.02 s−1 (Johnson et al., 2000)
to 1.2 s−1. This suggests the Ser-305 residue is involved
in DNA binding, which is consistent with its location near
the DNA binding pocket (Figure 1). The P1073L mutant
showed a koﬀ -value similar to the wild-type enzyme (data not
shown).
Single-Nucleotide Incorporation Kinetics
The enzyme was pre-incubated with DNA template (25-mer/45-
mer) to form the binary complex, and it was rapidly mixed
with a solution containing the correct incoming nucleotide
(dATP) at various concentrations. The nucleotide concentra-
tion dependence of the rate of the rapid burst of polymer-
ization provided estimates of an apparent nucleotide disso-
ciation constant (Kd,app) and a maximum rate of nucleotide
incorporation (kpol) according to Scheme 1 as described pre-
viously (Batabyal et al., 2010). Figures 2B,C shows the time
course of product formation (26-mer) at several nucleotide con-
centrations observed for S305R and P1073L mutants, respec-
tively. In Figure 2B, some data were taken from Figure 4A
published previously (Qian et al., 2014) with the addition of
data collected from experiments using lower concentrations of
dATP. The data deﬁning nucleotide incorporation were ﬁt glob-
ally to the mechanism shown in Scheme 1 to obtain the kpol
and Kd,app.
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FIGURE 2 | Kinetic analysis of S305R and P1073L mutant. (A) Active site
titration of S305R mutant. The S305R mutant (100 nM) was preincubated with
350 nM DNA template (25-mer/45-mer) for 10 min on ice. The binary complex
was then rapidly mixed with 10 mM Mg2+ and 50 μM dATP (correct incoming
nucleotide). The reaction was allowed to proceed for variable times before
quenched by 250 mM EDTA. The product was resolved on a 15% denaturing
polyacrylamide gel as shown in the upper panel, quantified and plotted against
the reaction time in the lower panel. The data were fit to a burst equation as
indicated in the text. (B) Kinetic incorporation of dATP for S305R mutant and
P1073L mutant (C). For each concentration series, a preformed enzyme-DNA
complex ([enzyme] > [DNA]) was mixed with variable concentrations of
nucleotide (0.05, 0.2, 0.4, 1, 6, and 17 μM) for S305R mutant (B) and (0.2, 0.5,
1.5, 3, 5, and 10 μM) for P1073L mutant (C), respectively, and then quenched
with 250 mM EDTA. Some of data shown in (B) were collected from (Qian et al.,
2014). In each panel, the smooth lines represent the best fit to the model shown
in Scheme 1 derived using KinTek Explorer software. The rate constants were
determined and shown in Table 1. The error analysis of data collected for the
S305R mutant was shown in Figure 3. (D) DNA concentration-dependent
kinetic incorporation of dATP for S305 mutant. The enzyme (55 nM) was
preincubated with variable concentration of DNA substrate (10, 30, 50, 100,
200, and 300 nM) and was mixed with 100 μM dATP and 12.5 mM Mg2+ for
varying time as indicated in the figure. (E) Excision of DNA containing a single
T–T mismatch at the 3′-terminal of the primer. Enzyme (100 nM) was
preincubated with 75 nM DNA substrate (25-mer/45-mer), and Mg2+ and
excess unlabeled DNA were added to initiate the cleavage reaction. The
remaining 25-mer was plotted against time and fit to a single exponential to
yield an excision rate of 0.34 ± 0.04 s−1 for wild-type enzyme, 0.11 ± 0.02 s−1
for S305R mutant, and 0.28 ± 0.03 s−1 for P1073L mutant.
E + D25
k1

k−1
E.D25
E.D25 + N
k2

k−2
E.D25.N
k3−→ E.D26 + PPi
E + D26
k1

k−1
E.D26 (Scheme 1)
Where D25 represents the DNA substrate (25-mer/45-mer)
and E.D25 represents a preformed complex of enzyme (E) with
DNA. Ground state nucleotide (N) binding is represented by
the term Kd,app, which can be derived by Kd,app = k−2/k2. The
nucleotide association rate (k2) is diﬀusion limited and was ﬁxed
at 0.5 nM−1s−1 for global data ﬁtting, whereas chemistry step to
form the complex of enzyme with 26-mer/45-mer (E.D26) and
pyrophosphate (PPi) is irreversible and described by kpol and
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kpol = k3. The DNA dissociation rate is described by koﬀ and
koﬀ = k−1, whereas the DNA association rate is kon and kon = k1.
According to the simpliﬁed model, the polymerization rate is
governed by a single rate-limiting step (kpol), and the ground state
nucleotide binding occurs as a fast equilibrium, while pyrophos-
phate release and translocation appear to be fast (Batabyal
et al., 2010). Therefore, the measured value of kpol/Kd,app deﬁnes
kcat/Km, the speciﬁcity constant governing nucleotide incorpora-
tion during processive polymerization. Interestingly, the P1073L
mutant showed a maximum rate of polymerization (Figure 2C)
and the value of kpol/Kd,app comparable to the wild-type enzyme
as summarized in Table 1. For the S305R mutant, a plot of
concentration of product with respect to the reaction time was
biphasic in nature (Figure 2B), displaying a fast nucleotide incor-
poration reaction followed by slower subsequent reactions. The
faster phase represents the incorporation of dATP in a single
turnover reaction. As the reaction proceeds, the slower phase
is rate-limited by the re-equilibration of enzyme-DNA binary
complex.
To accurately determine the eﬀect of S305R on DNA binding
aﬃnity, we performed another single nucleotide incorporation
assay, where the enzyme concentration was ﬁxed at 55 nM,
and the ﬁnal concentration of DNA was varied between 10 and
300 nM. The time dependence of product (26-mer) formation
for a representative set of DNA concentrations is shown in
Figure 2D. The data were then analyzed by ﬁtting the full time
course to the model (Scheme 1). Global ﬁtting of data shown in
Figures 2B,D deﬁnes the DNA association rate (kon), koﬀ, kpol,
and kcat/Km for S305R mutant. As shown in Table 1, the S305R
mutation caused a 2.5-fold reduction in kpol, a fourfold reduc-
tion in kcat/Km, and an overall 10-fold decrease in DNA-binding
aﬃnity.
Exonuclease Activity of S305R and P1073L
Mutant
The Ser305 is located near the exonuclease active site of Pol-
γA (Figure 1). To determine whether the mutation aﬀects the
proofreading activity of Pol-γ, we examined the excision of the 3′-
terminal base from the primer strand of DNA containing one T:T
mismatch. Cleavage was examined by mixing Mg2+ and excess
unlabeled DNA as a polymerase trap with a pre-formed enzyme-
labeled DNA binary complex. The fraction of remaining primer
(25-mer) was plotted against the reaction time (Figure 2E), and
the data were ﬁt to a single exponential equation. The S305R
mutation reduces the rate of excision of T:T mismatch from 0.34
to 0.11 s−1, while the P1073Lmutation appears to have no impact
TABLE 1 | Effects of S305R and P1073L mutations on dATP incorporation.
Kd,DNA
nM
kpol s−1 Kd,app
μM
kpol/Kd,app
μM−1s−1
kexos−1
WT∗ 9.9 ± 2.1 30 ± 2 0.7 ± 0.14 43 ± 9 0.34 ± 0.04
S305R 100 ± 4 12.4 ± 0.75 1.2 ± 0.15 10 ± 1 0.11 ± 0.02
P1073L 10.2 ± 1.2 54.2 ± 11.8 1.5 ± 0.5 36.1 ± 7 0.28 ± 0.03
∗The kinetic parameters for WT enzyme were determined previously (Johnson et al.,
2000; Batabyal et al., 2010).
on the exonuclease activity within the experimental uncertainty
(Table 1).
Confidence Contour Analysis
To determine whether the data collected in Figures 2B,D are suf-
ﬁcient to deﬁne four kinetic parameters (k1, k−1, k−2, and k3) in
ﬁtting to Scheme 1, a conﬁdence contour analysis was performed
as described previously (Johnson et al., 2009a,b). Figure 3 shows
the normalized χ2-values as a function of each parameter. The
results demonstrate all four kinetic parameters were well con-
strained by the data as indicated by the red central zone deﬁning
the area of good ﬁt. The yellow margin shows the threshold rep-
resenting a 10% increase in χ2, which is used to set the lower and
upper conﬁdence limits on each of the kinetic parameters.
Processive Polymerization by Wild-Type and
P1073L Pol-γ
The P1073L mutant shows wild-type activity in single-turnover
kinetics. We next examined the processivity of P1073L mutant
on a 25/45-mer DNA template. As shown in Figure 4C, a
preincubated solution of P1073L Pol-γ and 25/45-mer DNA
was reacted with dATP, dCTP, TTP (dGTP was absent so that
only ﬁve nucleotides were allowed to incorporate) for various
times before quenching with 0.5 M EDTA and analyzing by
polyacrylamide gel electrophoresis. The curves (Figure 4D) were
obtained by quantifying the amount of 25-mer through 30-mer
over time as the fractional concentration of each species at each
time point multiplied by the concentration of DNA. The solid
lines represent the global ﬁt of the data to a model for processive
incorporation (Scheme 2) of ﬁve single nucleotide incorporations
at rates of 65 s−1 (dATP), 36 s−1 (dCTP), 48 s−1 (dCTP), 28 s−1
(TTP), and 7 s−1 (dCTP), and a Kd,DNA = 15 nM. The wild-type
enzyme (Figures 4A,B) shows processive incorporation of 10
single nucleotide incorporations at rates of 37, 75, 60, 65, 70, 37,
73, 58, 70, and 46 s−1 and a Kd,DNA = 15 nM on a 25/73-mer
DNA template. The discrepancy between polymerization rates
could be base-dependent and sequence-context dependent.
Overall, the P1073L mutant shows no apparent defect in proces-
sive DNA synthesis.
ED25
kpol1−→ ED26
kpol2−→ ED27
kpol3−→ ED28
kpol4−→ ED29
kpol5−→ ED30
EDn
Kd
 E + Dn
(Scheme 2)
Replisome Polymerization Kinetics of S305R
and P1073L Mutant
Our attempts characterizing the enzyme activity for P1073L
mutation in Pol-γA catalytic subunit have failed to reveal a
measureable defect. Pro-1073 is located in a disordered loop
in the published structure (Figure 1). The presumption is that
P1073 may reﬂect interactions between Pol-γ and other compo-
nents of the replisome, notably the TWINKLE. To test this, we
have assembled a minimal replisome containing Pol-γ (50 nM),
TWINKLE (50 nM), and mtSSB (500 nM) on a mini-circle tem-
plate (2.5 nM) to examine leading-stranding synthesis (Qian
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FIGURE 3 | Confidence contour analysis. The error limits of the four
rate constants governing the kinetic pathway of nucleotide incorporation
by S305R mutant, were investigated by confidence contour analysis of
pair wise combinations of the four rate constants as described previously
(Johnson et al., 2009a,b). The results were derived by globally fitting the
data as shown in Figures 2B,D and were displayed as a normalized
χ2-values as a function of each parameter. The central red zone shows
the area of good fit, and the yellow band between the red and green
zones shows the threshold representing a 10% increase in χ2 (Johnson
et al., 2009b).
et al., 2013). The wild-type enzyme shows long products being
synthesized through rolling-circle replication, while no prod-
ucts were seen with the S305R mutant (Figure 5A). The data
are consistent with our previous observation that the S305R
mutant failed to support replication in haploid yeast cells (Qian
et al., 2014). Interestingly, the P1073L mutation caused approx-
imately a twofold reduction in the net polymerization rate in
the replisome assay. To examine whether the defect is due to
the impaired interaction between Pol-γ and mtSSB, we repeated
the experiment by excluding the mtSSB in the reaction, simi-
lar results were obtained as shown in Figure 5B, suggesting that
P1073L mutation may disturb the interaction between Pol-γ and
TWINKLE.
To approximate the compound heterozygote seen clinically,
we mixed equal parts of the twomutant enzymes to get the results
in the column labeled S305R/P1073L. Under these conditions,
the S305R mutant only slightly reduced the net rate of poly-
merization catalyzed by the P1073L mutant. This result can be
explained by the weaker DNAbinding aﬃnity of S305Rmutant so
that the S305Rmutant does not interfere with the polymerization
catalyzed by the P1073L mutant.
Effects of S305R and P1073L Mutation on
mtDNA Replication in Humanized Yeast
We have shown in our previous work (Qian et al., 2014) that
human Pol-γ can complement yeast MIP1 knockouts in mito-
chondria maintenance. Yeast carrying the human enzyme with
an S305R mutation in Pol-γ showed a complete loss of mtDNA
content in haploid cells, while in diploid cells (with one wild-
type allele), we observed a decreased growth rate, correlating
with loss of mtDNA content and increased mtDNA mutation
frequency over time (Qian et al., 2014). In comparison, yeast hap-
loid cells expressing Pol-γ (P1073L) retained 30–40% of mtDNA
content relative to that of cells expressing the wild-type Pol-γ
(Figure 6), but the P1073L strain showed ∼fourfold increase in
mtDNA mutation frequency determined by the percentage of
cells resistant to erythromycin (Table 2). In both heterozygous
diploid strains: WT/S305R and WT/P1073L, the mtDNA con-
tents retained at least 80% relative to the WT/WT diploid strains
(Figure 6), suggesting the wild-type enzyme can compensate for
deﬁciencies in the rates of replication catalyzed by the mutant
forms. However, both heterozygous diploid cells showed elevated
mtDNA mutation frequency: ∼eightfold increase for WT/S305R
Frontiers in Genetics | www.frontiersin.org 7 April 2015 | Volume 6 | Article 135
Qian et al. Alpers mutations by distinct mechanisms
FIGURE 4 | Processive polymerization by wild-type and mutant P1073L
polymerase gamma (Pol-γ). (A) A preincubated solution of wild-type Pol-γ
and 25/73mer DNA was reacted with dATP, dGTP, TTP (5 μM each) in
buffer containing 12.5 mM MgCl2 for various times before quenching with
0.5 M EDTA and analyzing by polyacrylamide gel electrophoresis (15%, 8 M
urea). (B) The curves were obtained by quantifying the amount of 25-mer
through 35-mer over time as the fractional concentration of each species at
each time point multiplied by the concentration of DNA. The solid lines
represent the global fit of the data to a model for processive incorporation of
10 single nucleotide incorporations at rates of 37, 75, 60, 65, 70, 37, 73,
58, 70, and 46 s−1 and a Kd,DNA = 15 nM. (C) A preincubated solution of
P1073L Pol-γ and 25/45mer DNA was reacted with dATP, dCTP, TTP (5 μM
each) in buffer containing 12.5 mM MgCl2 for various times before
quenching with 0.5 M EDTA and analyzing by polyacrylamide gel
electrophoresis (15%, 8 M urea). (D) The curves were obtained by
quantifying the amount of 25-mer through 30-mer over time as the fractional
concentration of each species at each time point multiplied by the
concentration of DNA. The solid lines represent the global fit of the data to a
model for processive incorporation of five single nucleotide incorporations at
rates of 65, 36, 48, 28, and 7 s−1 and a Kd,DNA = 15 nM.
diploid cells and ∼fourfold increase for WT/P1073L diploid
strains. Diploid cells carrying S305R/P1073L mutations to mimic
the compound heterozygotes of human Pol-γ mutations, showed
more dramatic mitochondrial deﬁciency with ∼80% reduction
of mtDNA content, and ∼25-fold increase of mtDNA mutation
frequency (Figure 6 and Table 2).
Discussion
There is a large gap in our understanding of the struc-
ture/function relationships underlying mtDNA replication. With
a given mutation one would like to deﬁne the changes in kinet-
ics of polymerization and to understand how biochemical defects
lead to the observed phenotype. In particular it is important
to understand the extent to which a wild-type enzyme com-
pensates for a defective polymerase, what attributes cause a
mutant enzyme to interfere with the functioning of a wild-
type enzyme, and how diﬀerent mutations in compound het-
erozygotes interact to produce more severe phenotypes. In this
work, we started to address these questions by characterizing
two Alpers mutations S305R and P1073L, using complemen-
tary approaches including examining the eﬀect of mutations on
DNA polymerization eﬃciency (kcat/Km), ﬁdelity, and the net
DNA replication eﬃciency in a reconstituted replisome, and by
monitoring the physiological eﬀect of mutations in a humanized
yeast with the endogenous yeast mitochondrial DNA polymerase
(MIP1) replaced by human Pol-γ.
Serine 305 lies in a loop-helix motif adjacent to a disor-
dered loop (residues A1034 to E1090) in the exonuclease domain
(Figure 1); it is noteworthy that residues in this motif are highly
conserved from yeast MIP1 to human Pol-γ (Szczepanowska and
Foury, 2010). Szczepanowska and Foury (2010) analyzed the bio-
chemical defects of equivalent mutations (L304R, R309H, R309L,
andW312R) in this motif in yeast MIP1 and all variants exhibited
reduced DNA-binding aﬃnity. Our data show that the human
Pol-γ (S305R) mutant had a 10-fold reduction in DNA-binding
aﬃnity, which is primarily caused by a faster DNA dissociation
rate (Figure 2A). Thus, the primary eﬀect of the S305R mutation
on the polymerase activity is attributed to the reduction of the
processivity as determined by kpol/koﬀ from ∼2000 nt (wild-type
enzyme) to ∼10 nt. Consistently, the S305Rmutant failed to syn-
thesize detectable long DNA in our reconstituted replisome assay
(Figure 5), and yeast haploid strain carrying S305R mutation
showed 100% petite phenotype (Qian et al., 2014) and a com-
pletely loss of mtDNA content. In humans diagnosed with Alpers
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FIGURE 5 | Rolling-circle DNA replication by the reconstituted mtDNA
replisome. Results are shown for WT, S305R, P1073L, and the combination
S305R/P1073L mutants. Size markers are given in kb. The reaction was run
using 50 nM Pol-γ (WT or mutant), 50 nM TWINKLE, and 0.5 μM mtSSB (A)
or without mtSSB (B), added after 60 s, in the presence of 250 μM of each of
the four dNTP’s and 3.6 mM ATP. Products formed after 10, 30, and 60 min
were resolved on an alkaline agarose gel to get results shown.
syndrome, the S305R mutation is always found in trans with
another mutation (A467T, P1073L, or R627Q; Baruﬃni et al.,
2011; Tang et al., 2011; Farnum et al., 2014). The A467T muta-
tion has been shown to reduce the DNA-binding aﬃnity due to
the compromised interaction between Pol-γA and Pol-γB (Chan
et al., 2005). Thus, it can be predicted that neither S305R nor
the A467T mutant is able to eﬃciently utilize the DNA tem-
plate for processive mtDNA replication in vivo, which leads to
mtDNA depletion that is commonly seen in patients with Alpers
syndrome (Wong et al., 2008).
The molecular mechanism of the pathogenicity of
S305R/P1073L and S305R/R627Q compound heterozy-
gote mutations, nevertheless, is likely to be diﬀerent from
S305R/A467T mutations. Kinetic analysis of the puriﬁed P1073L
enzyme shows wild-type behavior in the DNA-binding aﬃnity,
FIGURE 6 | Relative mtDNA content of different humanized yeast
strains. The copy number of the mitochondria COX3 gene relative to that of
the nuclear GAL4 gene by q-PCR was normalized to 1 for POLG(WT) haploid
strain and POLG(WT)/POLG(WT) diploid strain as described previously (Qian
et al., 2014).The genomic DNA was extracted from cells harvested at
OD = 1.0. The data for S305R haploid and S305R/WT diploid cells were
determined previously (Qian et al., 2014).
TABLE 2 | mtDNA mutation frequency as measured by EryR cells.
Strains EryR(10−7)
POLG(WT) 2.3 ± 0.2
POLG(S305R) Not available
POLG(P1073L) 7.2 ± 1.1
POLG(WT)/POLG(WT) 1.5 ± 0.5
POLG(WT)/POLG(S305R)∗ 9 ± 1.1
POLG(WT)/POLG(P1073L) 4.4 ± 0.6
POLG(S305R)/POLG(P1073L) 24 ± 2.1
∗Data was collected previously (Qian et al., 2014).
processivity, kcat/Km for correct nucleotide incorporation and
proofreading activity (Figures 2 and 4). Likewise, the R627Q
mutant (Luoma et al., 2005) exhibits normal DNA polymerase
activity, and slightly higher DNA-binding aﬃnity and pro-
cessivity. Our experimental data do not support the previous
proposal to cluster Alpers mutations based on structure-function
relationship based upon domain location alone (Euro et al.,
2011), which suggests that Pro-1073 and Ser-305 belong to the
same cluster and are involved in the same function involving the
partitioning of the primer strand between the pol and exo active
site by forming stable contacts with the DNA substrate (Euro
et al., 2011). Rather, the eﬀect of the P1073L mutation appears to
be subtler.
Based upon available polymerase assays alone, one would have
been tempted to dismiss claims that the P1073L mutation (or
R627Q) was correlated genetically with mitochondrial disorders.
Here we show clearly in both the rolling circle assays and the
humanized yeast system that the P1073L mutation caused signif-
icant defects in mtDNA replication (Figures 5 and 6) through
mechanisms that remain to be established. Our results suggest
a role for Pro-1073 in the functioning of the Pol-γ with the
TWINKLE, based on its location in a disordered loop in the Pol-γ
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structure (Figure 1), but more deﬁnitive assays are needed to
quantify this eﬀect. Mutations in other residues in this disor-
dered loop, such as Alpers mutation R1074W, as well as PEO
mutations G1051R and G1076V, cause mtDNA instability to a
diﬀerent extent in the yeast system (Baruﬃni et al., 2007; Stumpf
et al., 2010), arguing the important role of this loop. Nevertheless,
detailed biochemical characterization of these mutants is needed
in order to fully understand the function of this loop.
Under physiological conditions, the inter-play between two
alleles primarily determines the consequences of mutations. Our
data shown in this work, as well as studies from other work
(Stumpf et al., 2010; Baruﬃni et al., 2011; Qian et al., 2014),
demonstrate that the wild-type allele can largely compensate for
the defects caused by the slow polymerization rate of a mutant
allele (Figure 6), and that the onset of growth defects is likely
due to the increased mutation frequency (Table 1). In fact, aging-
dependent accumulation of point mutations in various regions
of mtDNA were reported in human studies (Stumpf et al., 1999;
Wang et al., 2001; Bender et al., 2006), and the important role
of mtDNA mutation to disease progression is also supported
by the mouse model carrying the proofreading-deﬁcient Pol-γ
in several studies (Trifunovic et al., 2004; Kujoth et al., 2005;
Ross et al., 2013), which led to premature aging phenotype.
The signiﬁcance of mtDNA mutation in disease progression of
Alpers syndrome, was considered to be limited (Stumpf et al.,
2010), as compared to the impact of slow replication rates cat-
alyzed by mutant enzymes, and resulting in mtDNA depletion as
shown in several tissues of Alpers patients (Naviaux et al., 1999;
Naviaux and Nguyen, 2004). Consistently, the primary eﬀect of
S305R/P1073L in compound heterozygous states is reﬂected by
∼80% reduction in mtDNA content. Nevertheless, it is inter-
esting to note that the S305R/P1073L diploid strain showed
∼ﬁvefold increase of mtDNAmutation frequency (Table 2) com-
pared to the WT/P1073L diploid strain, arguing for a role of
mtDNAmutation in mitochondrial dysfunction and disease pro-
gression, which may be caused by the low ﬁdelity S305R enzyme
(Table 2).
Overall, we present evidence showing diﬀerent molecular and
kinetic mechanisms causing Alpers disease by S305R and P1073L
mutants. To our knowledge, this is the ﬁrst report that suggests
an important role of Pro-1073 in coordinating with other repli-
some components in processive mtDNA replication, although
further experiments are needed to test this postulate. We con-
clude that characterizing the deﬁciency of Pol-γ mutants in the
context of replisome as a whole is important for understanding
mitochondrial disease and for predicting disease severity.
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